| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4ccec559af3fbb7ed14a93545a62a76c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_56e11c3e561113ea25946d2f6f8f385a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea8363402291164c47904e9561931e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-368
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-811
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-817 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-689
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B10-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H10-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-76 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H10-40 |
| filingDate |
1995-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7adf7de7032b5ed5ea99936483dc6130
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_096a2da3f422e59a7cf239e47ab377bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ce1bb7e00cd9709a82e915194b9d051 |
| publicationDate |
1996-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2155919-A1 |
| titleOfInvention |
Antenatal screening for pregnancy abnormalities |
| abstract |
A method for antenatal screening for pregnancy abnormalities in which a sample of maternal body fluid from a pregnant woman is measured for the level of at least one marker and/or a precursor or metabolite of the marker. The measured level of this marker together with the gestational age of the woman are compared with reference values at various gestational ages of the level for the marker in (a) pregnant women carrying foetuses having abnormality(s) subject to the screen and/or (b) pregnant women carrying normal foetuses. The comparison is indicative of the risk of the pregnant woman carrying a foetus with an abnormality subject to the screen characterised in that the marker is dimeric inhibin. |
| priorityDate |
1994-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |